HOWL Werewolf Therapeutics, Inc. - Common Stock
$0,41
Prix · Aoû 19, 2026
Données fondamentales au Jul 31, 2026
Fourchette 52 semaines
$0–$2
7% of range
Note des analystes
STRONG BUY
10 analysts
Objectif de cours
$7
+1602% upside
P/E (TTM)
-0.3
ROE
-183.6%
Marge nette
—
HOWL Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.41
Capitalisation Boursière
$20M
P/E (TTM)
-0.3
BPA (TTM)
$-1.33
Revenus (TTM)
—
Rendement div.
—
ROE
-183.6%
Dette/Capitaux propres
1.1
Fourchette 52 semaines
$0 – $2
HOWL Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-1.33
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-60M
2021-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
HOWL
Médiane des pairs
P/E (TTM)
-0.3
—
P/B
0.8
3.3
EV / EBITDA
0.1
—
Price / FCF (Cours / FCF)
-0.3
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
HOWL
Médiane des pairs
ROA
-62.0%
-66.0%
ROE
-183.6%
-128.2%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
HOWL
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
1.1
1.0
Current Ratio (Ratio de liquidité)
1.6
2.6
Quick Ratio (Ratio de liquidité réduite)
1.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
HOWL
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
HOWL
Médiane des pairs
HOWL Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
10 analystes
- Achat fort 4 40,0%
- Achat 4 40,0%
- Conserver 2 20,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-08-18
Bas
$7.00
Haut
$7.00
Objectif médian
$7.00
+1601,5%
Objectif moyen
$7.00
+1601,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.08 | $-0.27 | 0.35% |
| 31 mars 2026 | $-0.28 | $-0.29 | 0.01% |
| 31 décembre 2025 | $-0.17 | $-0.35 | 0.18% |
| 30 septembre 2025 | $-0.36 | $-0.40 | 0.04% |
| 30 juin 2025 | $-0.40 | $-0.49 | 0.09% |
| 31 mars 2025 | $-0.40 | $-0.40 | 0.00% |
| 31 décembre 2024 | $-0.46 | $-0.43 | -0.03% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| CLRB | — | -0.4 | — | — | — | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| SKYE | $25M | -0.5 | — | — | -175.6% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| CYCN | — | -1.1 | 3.7% | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $45M | $56M | $42M | $54M | $35M | $17M | |
| SG&A Expense | $16M | $19M | $19M | $19M | $15M | $6M | |
| Operating Expenses | $61M | $75M | $60M | $72M | $50M | $22M | |
| Operating Income | $-61M | $-74M | $-41M | $-56M | $-50M | $-22M | |
| Interest Expense | · | · | $3M | $0 | · | · | |
| Interest Income | $3M | $7M | $7M | $2M | · | · | |
| Other Non-op | $2M | $2M | $-1M | $338.0K | $104.0K | $7M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-61M | $-71M | $-37M | $-54M | $-50M | $-15M | |
| EPS (Basic) | $-1.32 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| EPS (Diluted) | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| Shares (Basic) | 46,018,888 | 43,332,088 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| Shares (Diluted) | 46,810,252 | 43,859,664 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| EBITDA | $-61M | $-74M | $-41M | $-56M | $-50M | · |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $111M | $134M | $129M | $158M | $93M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $4M | $344.0K | |
| Current Assets | $59M | $113M | $138M | $140M | $161M | $93M | |
| PP&E (Net) | $5M | $6M | $8M | $9M | $3M | $651.0K | |
| PP&E (Gross) | $11M | $11M | $11M | $10M | $3M | $826.0K | |
| Accum. Depreciation | · | · | · | · | $391.0K | · | |
| Other Non-current Assets | $5.0K | $320.0K | $594.0K | $1M | $649.0K | $0 | |
| Total Assets | $69M | $127M | $175M | $160M | $179M | $96M | |
| Accounts Payable | $754.0K | $3M | $1M | $1M | $2M | $1M | |
| Accrued Liabilities | $5M | $11M | $9M | $14M | $9M | $4M | |
| Short-term Debt | $28M | $0 | $7M | $0 | · | · | |
| Current Liabilities | $36M | $15M | $19M | $24M | $12M | $5M | |
| Capital Leases | $8M | $9M | $11M | $13M | $15M | $2M | |
| Other Non-current Liabilities | · | · | $0 | $191.0K | $0 | $31.0K | |
| Total Liabilities | $45M | $54M | $63M | $38M | $26M | $7M | |
| Long-term Debt | $32M | $32M | $40M | · | · | · | |
| Total Debt | $28M | $0 | $7M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $500M | $488M | $455M | $429M | $406M | $0 | |
| Retained Earnings | $-475M | $-415M | $-344M | $-307M | $-253M | $-52M | |
| Stockholders' Equity | $25M | $73M | $111M | $122M | $153M | $-52M | |
| Liabilities + Equity | $69M | $127M | $175M | $160M | $179M | $96M | |
| Shares Outstanding | 48,596,817 | 44,827,159 | 39,107,048 | 31,515,074 | 27,313,000 | 1,184,000 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $8M | $7M | $4M | $632.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-60M | $-56M | $-33M | $-41M | $-43M | $-19M | |
| CapEx | $0 | $254.0K | $769.0K | $4M | $498.0K | $560.0K | |
| Investing Cash Flow | $0 | $-254.0K | $-769.0K | $-4M | $-498.0K | $-560.0K | |
| Stock Issued | $6M | $24M | $18M | $16M | $0 | · | |
| Net Stock Activity | $6M | $24M | $18M | $16M | · | · | |
| Financing Cash Flow | $6M | $13M | $58M | $16M | $109M | $94M | |
| Net Change in Cash | $-54M | $-43M | $25M | $-28M | $66M | $75M | |
| Free Cash Flow | $-60M | $-56M | $-33M | $-44M | $-43M | · |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -62.0% | -46.7% | -22.3% | -31.7% | -36.3% | · | |
| ROE | -183.6% | -86.6% | -33.4% | -42.5% | -31.0% | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 | · | |
| Quick Ratio | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 | · | |
| Debt / Equity | 1.1 | 0.0 | 0.1 | · | · | · | |
| Interest Coverage | · | · | -12.9 | · | · | · |
Valorisation (TTM) 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-61M | $-71M | $-37M | $-54M | $-50M | · | |
| Market Cap | $31M | $66M | $151M | $64M | $325M | · | |
| Enterprise Value | $2M | $-45M | $23M | · | · | · | |
| P/E | -0.5 | -0.9 | -3.7 | -1.1 | -1.1 | · | |
| P/B | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Tangible Book | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Cash Flow | -0.5 | -1.2 | -4.6 | -1.6 | -7.6 | · | |
| P / FCF | -0.5 | -1.2 | -4.5 | -1.5 | -7.5 | · | |
| EV / EBITDA | -0.0 | 0.6 | -0.6 | · | · | · | |
| EV / FCF | -0.0 | 0.8 | -0.7 | · | · | · | |
| Earnings Yield | -209.8% | -110.1% | -27.2% | -90.7% | -91.9% | · |
Compte de résultat 13
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $8M | $7M | $12M | $13M | $13M | $16M | $13M | $15M | $13M | $10M | $11M | $10M | $12M | $16M | $13M | |
| SG&A Expense | $8M | $5M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $14M | $13M | $9M | $16M | $18M | $18M | $20M | $17M | $20M | $18M | $14M | $15M | $14M | $17M | $20M | $18M | |
| Operating Income | $7M | $-13M | $-9M | $-16M | $-18M | $-18M | $-20M | $-17M | $-19M | $-17M | $-13M | $-9M | $-6M | $-12M | $-13M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $172.0K | · | · | |
| Interest Income | $277.0K | $433.0K | $564.0K | $697.0K | $850.0K | $997.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Other Non-op | $64.0K | $674.0K | $2M | $0 | $11.0K | $168.0K | $-94.0K | $97.0K | $2M | $-1.0K | $-6.0K | $-5.0K | $-25.0K | $-1M | $70.0K | $3.0K | |
| Net Income | $4M | $-14M | $-8M | $-16M | $-18M | $-18M | $-20M | $-17M | $-17M | $-16M | $-12M | $-8M | $-5M | $-12M | $-12M | $-12M | |
| EPS (Basic) | $0.08 | $-0.28 | $-0.16 | $-0.36 | $-0.40 | $-0.40 | $-0.46 | $-0.38 | $-0.40 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| EPS (Diluted) | $0.08 | $-0.28 | $-0.17 | $-0.36 | $-0.40 | $-0.40 | $-0.43 | $-0.38 | $-0.43 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| Shares (Basic) | 48,597,534 | 48,596,817 | -89,594,059 | 45,804,042 | 44,981,746 | 44,827,159 | -85,501,433 | 43,704,836 | 43,521,406 | 41,607,279 | -70,349,735 | 35,653,924 | 35,557,701 | 34,784,682 | -55,810,065 | 29,764,000 | |
| Shares (Diluted) | 48,597,534 | 49,388,181 | -88,802,695 | 45,804,042 | 44,981,746 | 44,827,159 | -85,495,635 | 43,704,836 | 44,043,184 | 41,607,279 | -70,349,735 | 35,653,924 | 35,557,701 | 34,784,682 | -55,810,065 | 29,764,000 | |
| EBITDA | $7M | $-13M | · | $-16M | $-18M | $-18M | · | $-17M | $-19M | $-17M | · | $-9M | $-6M | $-12M | · | $-13M |
Bilan 23
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $46M | $57M | $66M | $78M | $92M | $111M | $123M | $135M | $139M | $134M | $130M | $137M | $148M | $129M | $140M | |
| Prepaid Expense | $905.0K | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $4M | $7M | |
| Current Assets | $23M | $49M | $59M | $68M | $80M | $94M | $113M | $126M | $139M | $142M | $138M | $139M | $147M | $157M | $140M | $152M | |
| PP&E (Net) | $1M | $4M | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | |
| PP&E (Gross) | · | · | $11M | · | · | · | $11M | · | · | · | $11M | · | · | · | $10M | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $992.0K | |
| Other Non-current Assets | $0 | $0 | $5.0K | $46.0K | $122.0K | $179.0K | $320.0K | $42.0K | $265.0K | $248.0K | $594.0K | $516.0K | $652.0K | $670.0K | $1M | $2M | |
| Total Assets | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Accounts Payable | $2M | $4M | $754.0K | $1M | $3M | $986.0K | $3M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $6M | $5M | $5M | $9M | $9M | $9M | $11M | $10M | $9M | $6M | $9M | $8M | $10M | $13M | $14M | $14M | |
| Short-term Debt | $0 | $29M | $28M | $6M | $2M | · | $0 | $0 | $0 | $12M | $7M | $2M | · | · | $0 | · | |
| Current Liabilities | $8M | $39M | $36M | $18M | $15M | $12M | $15M | $12M | $11M | $21M | $19M | $14M | $15M | $22M | $24M | $28M | |
| Capital Leases | $0 | $7M | $8M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $191.0K | $191.0K | |
| Total Liabilities | $8M | $46M | $45M | $50M | $51M | $50M | $54M | $51M | $50M | $60M | $63M | $64M | $67M | $74M | $38M | $41M | |
| Long-term Debt | · | $32M | $32M | $32M | $32M | $32M | · | $32M | $32M | $40M | · | · | · | · | · | · | |
| Total Debt | $0 | $29M | · | $6M | $2M | · | · | $0 | $0 | $12M | · | $2M | · | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $502M | $501M | $500M | $497M | $492M | $490M | $488M | $484M | $482M | $478M | $455M | $445M | $442M | $440M | $429M | $426M | |
| Retained Earnings | $-485M | $-489M | $-475M | $-467M | $-451M | $-433M | $-415M | $-394M | $-378M | $-360M | $-344M | $-332M | $-324M | $-319M | $-307M | $-295M | |
| Stockholders' Equity | $16M | $12M | $25M | $30M | $41M | $57M | $73M | $89M | $104M | $118M | $111M | $112M | $119M | $121M | $122M | $131M | |
| Liabilities + Equity | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Shares Outstanding | 48,599,066 | 48,596,817 | 48,596,817 | 47,273,685 | 45,335,265 | 44,827,159 | 44,827,159 | 43,721,772 | 43,702,147 | 43,282,371 | 39,107,048 | 35,658,000 | 35,642,000 | 35,301,000 | 31,433,731 | 30,611,000 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $419.0K | $929.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $7M | $-11M | $-11M | $-15M | $-15M | $-19M | $-14M | $-12M | $-14M | $-15M | $-5M | $-7M | $-11M | $-10M | $-12M | $-14M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $123.0K | $3.0K | $17.0K | $111.0K | $198.0K | $221.0K | $182.0K | $168.0K | $518.0K | $2M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | $0 | $-123.0K | $-3.0K | $-17.0K | $-111.0K | $-198.0K | $-221.0K | $-182.0K | $-168.0K | $-518.0K | $-2M | |
| Stock Issued | · | · | $2M | $3M | $347.0K | $0 | $2M | $-29.0K | $877.0K | $20M | $9M | $-84.0K | $552.0K | $9M | $979.0K | $11M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $20M | · | · | · | $9M | · | · | |
| Financing Cash Flow | · | · | $2M | $3M | $388.0K | $0 | $3M | $-6.0K | $-10M | $20M | $9M | $41.0K | $692.0K | $49M | $1M | $11M | |
| Net Change in Cash | $-25M | $-11M | $-9M | $-12M | $-15M | $-19M | $-12M | $-12M | $-24M | $5M | $4M | $-7M | $-10M | $39M | $-11M | $-5M | |
| Free Cash Flow | · | · | · | · | · | $-19M | · | · | · | $-15M | · | · | · | $-10M | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 6.3% | -16.4% | · | -14.9% | -14.6% | -12.7% | · | -10.5% | -10.2% | -8.7% | · | -4.8% | -2.8% | -6.7% | · | -6.8% | |
| ROE | 12.7% | -38.9% | · | -27.5% | -24.7% | -20.7% | · | -16.5% | -15.5% | -13.6% | · | -6.8% | -4.1% | -9.2% | · | -8.0% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 1.3 | · | 3.9 | 5.3 | 8.1 | · | 10.1 | 12.1 | 6.7 | · | 9.6 | 9.8 | 7.2 | · | 5.5 | |
| Quick Ratio | 2.8 | 1.2 | · | 3.7 | 5.1 | 7.9 | · | 9.9 | 11.8 | 6.6 | · | 9.0 | 9.2 | 6.8 | · | 5.1 | |
| Debt / Equity | 0.0 | 2.4 | · | 0.2 | 0.1 | · | · | 0.0 | 0.0 | 0.1 | · | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.1 | · | · | · | · | · | · |
Valorisation (TTM) 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-44M | $-66M | · | $-69M | $-70M | $-68M | · | $-58M | $-47M | $-42M | · | $-37M | $-44M | $-54M | · | $-56M | |
| Market Cap | $17M | $40M | · | $93M | $49M | $44M | · | $93M | $107M | $280M | · | $76M | $109M | $92M | · | $138M | |
| Enterprise Value | $-4M | $23M | · | $33M | $-26M | · | · | $-30M | $-29M | $153M | · | $-52M | · | · | · | · | |
| P/E | -0.4 | -0.6 | · | -1.3 | -0.7 | -0.6 | · | -1.5 | -2.1 | -5.9 | · | -1.9 | -2.2 | -1.4 | · | -2.3 | |
| P/B | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Tangible Book | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Cash Flow | · | -3.8 | · | · | · | -2.3 | · | · | · | -18.3 | · | · | · | -9.3 | · | · | |
| P / FCF | · | · | · | · | · | -2.3 | · | · | · | -18.2 | · | · | · | -9.1 | · | · | |
| EV / EBITDA | -0.6 | -1.7 | · | -2.1 | 1.5 | · | · | 1.8 | 1.5 | -8.9 | · | 5.6 | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -9.9 | · | · | · | · | · | · | |
| Earnings Yield | -266.7% | -172.9% | · | -78.2% | -147.7% | -164.6% | · | -67.5% | -48.8% | -17.0% | · | -51.9% | -46.2% | -70.4% | · | -44.4% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-61M | $-71M | $-37M | $-54M | $-50M |
| BPA dilué | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 1.1 | 0.0 | 0.1 | — | — |
| Ratio de liquidité | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 |
| Ratio de liquidité réduite | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-60M | $-56M | $-33M | $-44M | $-43M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 54 déclarants · $12.4M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 13 (+6 vs T. préc.) | 10 (-1 vs T. préc.) | 9 (+2 vs T. préc.) | 8 (-3 vs T. préc.) | -1.9M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | $8 490 424 | 4 309 860 | 68,38% | Actions |
| RA CAPITAL MANAGEMENT, L.P. | $859 349 | 2 387 744 | 6,92% | Actions |
| Balyasny Asset Management L.P. | $644 253 | 1 790 089 | 5,19% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $438 471 | 1 217 976 | 3,53% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $242 800 | 674 632 | 1,96% | Actions |
| Lynx1 Capital Management LP | $236 737 | 657 786 | 1,91% | Actions |
| SPHERA FUNDS MANAGEMENT LTD. | $225 589 | 626 810 | 1,82% | Actions |
| DC Funds, LP | $212 018 | 589 102 | 1,71% | Actions |
| Verdad Advisers, LP | $125 500 | 348 709 | 1,01% | Actions |
| VANGUARD GROUP INC | $113 948 | 179 728 | 0,92% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $98 563 | 273 764 | 0,79% | Actions |
| XTX Topco Ltd | $97 705 | 271 478 | 0,79% | Actions |
| Cubist Systematic Strategies, LLC | $92 020 | 46 711 | 0,74% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $56 781 | 157 726 | 0,46% | Actions |
| JANE STREET GROUP, LLC | $52 752 | 146 573 | 0,42% | Actions |
| STATE STREET CORP | $42 889 | 119 168 | 0,35% | Actions |
| Squarepoint Ops LLC | $37 157 | 103 242 | 0,30% | Actions |
| Rangeley Capital, LLC | $35 990 | 100 000 | 0,29% | Actions |
| Nuveen Asset Management, LLC | $31 557 | 21 322 | 0,25% | Actions |
| NORTHERN TRUST CORP | $31 258 | 86 851 | 0,25% | Actions |
| Alyeska Investment Group, L.P. | $31 151 | 86 554 | 0,25% | Actions |
| MPM BIOIMPACT LLC | $28 851 | 80 142 | 0,23% | Actions |
| CITADEL ADVISORS LLC | $26 993 | 75 000 | 0,22% | Option d'achat |
| Point72 Asia (Singapore) Pte. Ltd. | $25 642 | 13 016 | 0,21% | Actions |
| MILLENNIUM MANAGEMENT LLC | $22 334 | 62 055 | 0,18% | Actions |
| H D Vest Advisory Services | $11 118 | 10 200 | 0,09% | Actions |
| BlackRock, Inc. | $10 661 | 29 623 | 0,09% | Actions |
| TWO SIGMA INVESTMENTS, LP | $9 825 | 27 300 | 0,08% | Actions |
| StoneX Group Inc. | $9 000 | 20 000 | 0,07% | Actions |
| BANK OF AMERICA CORP /DE/ | $8 331 | 23 206 | 0,07% | Actions |
| GOLDMAN SACHS GROUP INC | $7 206 | 20 023 | 0,06% | Actions |
| TWO SIGMA ADVISERS, LP | $6 525 | 10 300 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $5 578 | 15 500 | 0,04% | Option de vente |
| CERTUITY, LLC | $5 399 | 15 000 | 0,04% | Actions |
| HBK Sorce Advisory LLC | $5 317 | 13 227 | 0,04% | Actions |
| BARCLAYS PLC | $4 763 | 13 235 | 0,04% | Actions |
| Larson Financial Group LLC | $4 697 | 13 052 | 0,04% | Actions |
| LPL Financial LLC | $4 244 | 11 791 | 0,03% | Actions |
| Ranch Capital Advisors Inc. | $3 959 | 11 000 | 0,03% | Actions |
| Marest Capital, LLC | $3 912 | 10 870 | 0,03% | Actions |
| Cetera Investment Advisers | $3 671 | 10 200 | 0,03% | Actions |
| Tower Research Capital LLC (TRC) | $3 562 | 9 897 | 0,03% | Actions |
| OSAIC HOLDINGS, INC. | $3 087 | 8 575 | 0,02% | Actions |
| Financial Perspectives, Inc | $2 429 | 6 750 | 0,02% | Actions |
| MORGAN STANLEY | $678 | 1 885 | 0,01% | Actions |
| GROUP ONE TRADING LLC | $673 | 1 871 | 0,01% | Actions |
| JPMORGAN CHASE & CO | $287 | 931 | 0,00% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $284 | 790 | 0,00% | Actions |
| SIMPLEX TRADING, LLC | $91 | 255 | 0,00% | Actions |
| UBS Group AG | $37 | 102 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $36 | 100 | 0,00% | Actions |
| Virtu Financial LLC | $16 | 45 467 | 0,00% | Actions |
| GSA CAPITAL PARTNERS LLP | $10 | 27 146 | 0,00% | Actions |
| Optiver Holding B.V. | $8 | 22 | 0,00% | Actions |
Initiés de la société 20 initiés · 6 dirigeants · 10 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel J Hicklin | President and Chief Executive Officer | 2 janvier 2025 A | — | 0 | 0 | $0 |
| Timothy W. Trost | Chief Financial Officer | 2 janvier 2025 A | — | 0 | 0 | $0 |
| Chulani Karunatilake | Chief Technology Officer | 2 janvier 2025 A | — | 0 | 0 | $0 |
| Ellen Lubman | Chief Business Officer | 2 janvier 2025 A | — | 0 | 0 | $0 |
| Randi Isaacs | Chief Medical Officer | 2 janvier 2025 A | — | 0 | 0 | $0 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | 2 janvier 2024 A | 164 888 | 0 | 0 | $0 |
| Luke Evnin | Administrateur | 7 juillet 2026 S | 0 | 0 | 87 | $-3 255 563 |
| Michael B. Atkins | Administrateur | 12 juin 2025 A | — | 0 | 0 | $0 |
| Anil K. Singhal | Administrateur | 12 juin 2025 A | — | 0 | 0 | $0 |
| Meeta Chatterjee | Administrateur | 12 juin 2025 A | — | 0 | 0 | $0 |
| Alon Lazarus | Administrateur | 12 juin 2025 A | 2 046 634 | 0 | 0 | $0 |
| Briggs Morrison | Administrateur | 12 juin 2025 A | — | 0 | 0 | $0 |
| Michael A. Sherman | Administrateur | 12 juin 2025 A | — | 0 | 0 | $0 |
| Derek Dirocco | Administrateur | 24 mai 2024 A | — | 0 | 0 | $0 |
| Sakae Asanuma | Administrateur | 4 mai 2021 C | 2 068 909 | 0 | 0 | $0 |
| Taiho Ventures LLC | Détenteur de 10% | 4 mai 2021 C | 2 068 909 | 0 | 0 | $0 |
| UPMC | Détenteur de 10% | 4 mai 2021 C | 1 097 756 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Détenteur de 10% | 4 mai 2021 C | 625 995 | 0 | 0 | $0 |
| Steven H. Bloom | — | 1 mai 2025 A | — | 0 | 0 | $0 |
| Reid Leonard | — | 3 janvier 2023 A | 14 102 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×13 dépôts | 2 juillet 2026 | 4,10% | Amendement | — | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, UBS Oncology Impact Fund L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, Oncology Impact Fund (Cayman) Management L.P., MPM BioImpact LLC, ANSBERT GADICKE, LUKE EVNIN, Todd Foley, MPM ASSET MANAGEMENT LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC ×8 dépôts | 12 mai 2026 | 3,80% | Amendement | — | SEC |
| Taiho Ventures LLC | 13 mai 2021 | — | Dépôt initial | Campagne de conseil d'administration | SEC |
| Arkin Bio Ventures 2 L.P., Arkin Bio Venture GPGP Ltd., Moshe Arkin, Alon Lazarus | 10 mai 2021 | — | Dépôt initial | Campagne de conseil d'administration | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 2 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.